The Global (R)-2-Hexylamine (CAS 70095-40-8) Market was valued at USD 28.4 Million in 2025 and is projected to reach USD 52.6 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period (2025–2034). This growth is being driven by the expanding pharmaceutical industry’s reliance on chiral intermediates, rising demand for enantioselective synthesis in agrochemicals, and the accelerating adoption of high-purity enantiomers across drug development and specialty chemical sectors.

As the fine chemicals industry transforms toward stereoselective processes and sustainable manufacturing, the spotlight is on the key producers who are driving innovation, efficiency, and advanced chiral pathways. In this blog, we profile the Top 10 Companies in the (R)-2-Hexylamine (CAS 70095-40-8) Industry—a mix of chemical majors, fine chemical specialists, and chiral synthesis pioneers shaping the future of global enantiomer production.

---

🔟 1. Laurus Labs Ltd.

Headquarters: Hyderabad, India
Key Offering: Pharmaceutical grade (R)-2-Hexylamine, chiral intermediates

Laurus Labs is a leading CDMO player in India, specializing in APIs and chiral building blocks for the pharmaceutical sector. The company supplies high-purity (R)-2-Hexylamine to global drug manufacturers, leveraging its expertise in asymmetric synthesis for antiviral and oncology applications. Their facilities are equipped for large-scale production while maintaining enantiomeric excess above 99%.

Chiral Technology Initiatives:

• Green chemistry processes for chiral amine synthesis

• Partnerships with pharma majors for custom enantiomer supply

• Expansion of biocatalytic capabilities targeting cost reduction

Download FREE Sample Report: (R)-2-Hexylamine (CAS 70095-40-8) Market – View in Detailed Research Report

---

9️⃣ 2. Piramal Pharma Solutions

Headquarters: Mumbai, India
Key Offering: (R)-2-Hexylamine for APIs, resolving agent services

Piramal Pharma Solutions excels in contract development for complex molecules, offering (R)-2-Hexylamine as a key chiral auxiliary in drug synthesis. Operating across multiple continents, they serve agrochemical and pharma clients with reliable supply chains and technical support for stereoselective reactions.

Chiral Technology Initiatives:

• Advanced chromatography for enantiomer purification

• IP-protected processes for high-value intermediates

---

8️⃣ 3. Asymchem Laboratories (Tianjin) Co., Ltd.

Headquarters: Tianjin, China
Key Offering: (R)-2-Hexylamine research and industrial grades

Asymchem is renowned for asymmetric catalysis expertise, producing (R)-2-Hexylamine for pharmaceutical intermediates and fine chemicals. Their state-of-the-art labs support early-stage drug discovery to commercial scale-up, focusing on efficiency in chiral resolutions.

Chiral Technology Initiatives:

• Ligand development for stereoselective hydrogenation

• Capacity expansion to meet Asia-Pacific pharma demand

• Collaborations with biotech firms for novel syntheses

---

7️⃣ 4. WuXi AppTec Co., Ltd.

Headquarters: Shanghai, China
Key Offering: (R)-2-Hexylamine building blocks, custom synthesis

WuXi AppTec dominates in integrated services for drug discovery, supplying (R)-2-Hexylamine from its vast building block library. They cater to global pharma pipelines with rapid delivery and high optical purity standards essential for therapeutic development.

Chiral Technology Initiatives:

• Automation in chiral pool expansion

• Goal of 10% annual increase in enantiopure catalog items

Download FREE Sample Report: (R)-2-Hexylamine (CAS 70095-40-8) Market – View in Detailed Research Report

---

6️⃣ 5. PharmaBlock Sciences Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Chiral amines including (R)-2-Hexylamine for APIs

PharmaBlock specializes in RSMs and chiral blocks, providing (R)-2-Hexylamine optimized for peptide coupling and ligand design. Their agile production serves diverse applications from antivirals to crop protection agents.

Chiral Technology Initiatives:

• Biocatalytic routes for sustainable production

• Focus on cost-efficient large-scale chiral separations

---

5️⃣ 6. Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: (R)-2-Hexylamine research grade, screening libraries

Enamine leads in chemical synthesis diversity, offering (R)-2-Hexylamine within its expansive screening compound collection. They support global R&D with custom enantiomers for hit-to-lead optimization in drug discovery.

Chiral Technology Initiatives:

• Over 1 million tons/year equivalent in library capacity

• Targeted expansion to 2 million by 2026 in chiral offerings

---

4️⃣ 7. Lonza Group Ltd.

Headquarters: Basel, Switzerland
Key Offering: High-purity (R)-2-Hexylamine for commercial pharma

Lonza is a global CDMO giant, utilizing (R)-2-Hexylamine in advanced bioconjugates and small molecule APIs. Their expertise in scale-up ensures seamless transition from lab to manufacturing for chiral-dependent therapeutics.

Chiral Technology Initiatives:

• Integration of flow chemistry for precise stereocontrol

• Strategic alliances for biocatalysis advancements

Download FREE Sample Report: (R)-2-Hexylamine (CAS 70095-40-8) Market – View in Detailed Research Report

---

3️⃣ 8. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Industrial grade (R)-2-Hexylamine, specialty amines

Evonik delivers robust chiral amine solutions, including (R)-2-Hexylamine for agrochemical intermediates. Their production emphasizes sustainability and high yields in selective pesticide development.

Chiral Technology Initiatives:

• Enzyme-based resolutions for eco-friendly processes

• R&D in next-gen catalysts for agro applications

---

2️⃣ 9. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: (R)-2-Hexylamine across pharma and agrochemicals

BASF, a chemical powerhouse, produces (R)-2-Hexylamine with integrated supply chains serving major global clients. They innovate in enantiopure herbicides and pharmaceuticals, balancing volume and purity.

Chiral Technology Initiatives:

• Advanced asymmetric catalysis platforms

• Expansion of production capacity by 25% to meet API needs

---

1️⃣ 10. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Premium (R)-2-Hexylamine, resolving agents

Merck KGaA tops the list as a chiral chemistry leader, supplying (R)-2-Hexylamine via Sigma-Aldrich integration for research to industrial scales. They dominate pharma intermediates with unmatched purity and global reach.

Chiral Technology Initiatives:

• Comprehensive chiral pool with >99% ee standards

• Post-merger enhancements in catalog and custom synthesis

• Partnerships accelerating enantioselective drug pipelines

Read Full Report: (R)-2-Hexylamine (CAS 70095-40-8) Market – View in Detailed Research Report

---

🌍 Outlook: The Future of (R)-2-Hexylamine Is Greener and More Selective

The (R)-2-Hexylamine market is undergoing a dynamic shift. While traditional resolutions dominate volume, the industry is investing heavily in biocatalytic alternatives, asymmetric technologies, and efficient supply networks.

📈 Key Trends Shaping the Market:

• Rapid biocatalysis capacity expansion in Europe, US, and Asia

• Regulatory mandates for enantiopure APIs boosting demand

• Digitalization of synthesis tracking and purity analytics

• Pharma-chemical alliances for chiral innovation

Read Full Report: (R)-2-Hexylamine (CAS 70095-40-8) Market – View in Detailed Research Report

The companies listed above are not only supplying chiral excellence—they’re spearheading the stereoselective revolution in chemistry.